nitroglycerin has been researched along with Hypertension, Essential in 4 studies
Nitroglycerin: A volatile vasodilator which relieves ANGINA PECTORIS by stimulating GUANYLATE CYCLASE and lowering cytosolic calcium. It is also sometimes used for TOCOLYSIS and explosives.
nitroglycerol : A nitrate ester that is glycerol in which nitro group(s) replace the hydrogen(s) attached to one or more of the hydroxy groups.
nitroglycerin : A nitroglycerol that is glycerol in which the hydrogen atoms of all three hydroxy groups are replaced by nitro groups. It acts as a prodrug, releasing nitric oxide to open blood vessels and so alleviate heart pain.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Correlation analysis showed in the overall population that the less NO and EETs bioavailability increases during heating, the more flow-mediated dilatation is reduced." | 1.51 | Altered bioavailability of epoxyeicosatrienoic acids is associated with conduit artery endothelial dysfunction in type 2 diabetic patients. ( Bellien, J; Cailleux, AF; Duflot, T; Iacob, M; Joannidès, R; Lamoureux, F; Leuillier, M; Li, D; Moreau-Grangé, L; Morisseau, C; Prévost, G; Rémy-Jouet, I; Renet, S; Richard, V; Roche, C; Wils, J, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Duflot, T | 1 |
| Moreau-Grangé, L | 1 |
| Roche, C | 1 |
| Iacob, M | 1 |
| Wils, J | 1 |
| Rémy-Jouet, I | 1 |
| Cailleux, AF | 1 |
| Leuillier, M | 1 |
| Renet, S | 1 |
| Li, D | 1 |
| Morisseau, C | 1 |
| Lamoureux, F | 1 |
| Richard, V | 1 |
| Prévost, G | 1 |
| Joannidès, R | 1 |
| Bellien, J | 1 |
| Ghiadoni, L | 1 |
| Francesconi, M | 1 |
| Taddei, S | 1 |
| Bruno, RM | 1 |
| Maruhashi, T | 1 |
| Nakashima, A | 1 |
| Kishimoto, S | 1 |
| Iwamoto, A | 1 |
| Kajikawa, M | 1 |
| Oda, N | 1 |
| Kihara, Y | 1 |
| Aibara, Y | 1 |
| Noma, K | 1 |
| Higashi, Y | 1 |
| Liu, Q | 1 |
| Liu, Y | 1 |
| Han, J | 1 |
| Li, J | 1 |
| Dong, S | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Determination of the Mechanisms Involved in Conduit Artery Endothelial Dysfunction in Type 2 Diabetes[NCT02311075] | 48 participants (Actual) | Interventional | 2014-12-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 other studies available for nitroglycerin and Hypertension, Essential
| Article | Year |
|---|---|
Altered bioavailability of epoxyeicosatrienoic acids is associated with conduit artery endothelial dysfunction in type 2 diabetic patients.
Topics: Aged; Biomarkers; Case-Control Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Eicosanoid | 2019 |
Hemodynamic and autonomic effects of low-dose glyceryl trinitrate used to test endothelium-independent vasodilation of the brachial artery.
Topics: Administration, Sublingual; Adult; Arterial Pressure; Brachial Artery; Cross-Over Studies; Dose-Resp | 2019 |
Reduction in blood pressure improves impaired nitroglycerine-induced vasodilation in patients with essential hypertension.
Topics: Adult; Aged; Essential Hypertension; Female; Humans; Hypertension; Male; Middle Aged; Nitric Oxide; | 2015 |
[Impact of visit-to-visit blood pressure variability on vascular function in elderly hypertensive patients].
Topics: Aged; Blood Pressure; Brachial Artery; Endothelium, Vascular; Essential Hypertension; Humans; Hypert | 2015 |